In the context of cancer, tyrosine kinases can become dysregulated, leading to uncontrolled cell proliferation and survival. Mutations, gene amplifications, or overexpression of tyrosine kinases can result in their constitutive activation, bypassing normal regulatory mechanisms. This aberrant activity is a hallmark of many cancers, including leukemia, lung cancer, breast cancer, and gastrointestinal stromal tumors.
